Tag: BLA (Biologics License Application)
China’s NMPA Accepts BLA for Zanidatamab in HER2+ Biliary Tract Cancer
China’s NMPA Accepts BLA for Zanidatamab in HER2+ Biliary Tract CancerThe National Medical Products Administration (NMPA) in China has approved the biologics license application...